These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 9679893)
1. Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens. Pettaway CA; Troncoso P; Ramirez EI; Johnston DA; Steelhammer L; Babaian RJ J Urol; 1998 Aug; 160(2):437-42. PubMed ID: 9679893 [TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532 [TBL] [Abstract][Full Text] [Related]
3. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers. Noguchi M; Stamey TA; McNeal JE; Yemoto CM J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712 [TBL] [Abstract][Full Text] [Related]
4. Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy. Bianco FJ; Wood DP; Grignon DJ; Sakr WA; Pontes JE; Powell IJ J Urol; 2002 Aug; 168(2):479-82. PubMed ID: 12131292 [TBL] [Abstract][Full Text] [Related]
5. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease. Powell IJ; Banerjee M; Novallo M; Sakr W; Grignon D; Wood DP; Pontes JE Urology; 2000 Feb; 55(2):246-51. PubMed ID: 10688088 [TBL] [Abstract][Full Text] [Related]
6. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men. Sanchez-Ortiz RF; Troncoso P; Babaian RJ; Lloreta J; Johnston DA; Pettaway CA Cancer; 2006 Jul; 107(1):75-82. PubMed ID: 16736511 [TBL] [Abstract][Full Text] [Related]
7. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. Eastham JA; Kattan MW J Urol; 2000 Jan; 163(1):143-5. PubMed ID: 10604332 [TBL] [Abstract][Full Text] [Related]
8. Multivariate analysis of race and adverse pathologic findings after radical prostatectomy. Freedland SJ; Dorey F; Aronson WJ Urology; 2000 Nov; 56(5):807-11. PubMed ID: 11068307 [TBL] [Abstract][Full Text] [Related]
9. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488 [TBL] [Abstract][Full Text] [Related]
10. Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients. Moul JW; Connelly RR; Mooneyhan RM; Zhang W; Sesterhenn IA; Mostofi FK; McLeod DG J Urol; 1999 Aug; 162(2):394-7. PubMed ID: 10411045 [TBL] [Abstract][Full Text] [Related]
11. Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men. Bissonette EA; Fulmer BR; Petroni GR; Moul JW; Theodorescu D J Urol; 2001 Oct; 166(4):1328-31; discussion 1331-2. PubMed ID: 11547067 [TBL] [Abstract][Full Text] [Related]
12. Calculating prostate cancer volume preoperatively: the D'Amico equation and some other observations. Chan LW; Stamey TA J Urol; 1998 Jun; 159(6):1998-2003. PubMed ID: 9598506 [TBL] [Abstract][Full Text] [Related]
13. Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database. Klaassen Z; Howard L; Terris MK; Aronson WJ; Cooperberg MR; Amling CL; Kane CJ; Freedland SJ Cancer Epidemiol; 2015 Dec; 39(6):1066-70. PubMed ID: 26452418 [TBL] [Abstract][Full Text] [Related]
14. Preoperative prostate specific antigen and prostate volume are significant predictors of seminal vesicle invasion in patients with prostate cancer. Sfoungaristos S; Perimenis P Prague Med Rep; 2011; 112(4):263-71. PubMed ID: 22142521 [TBL] [Abstract][Full Text] [Related]
15. Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men. Eastham JA; Carver B; Katz J; Kattan MW Prostate; 2002 Mar; 50(4):236-40. PubMed ID: 11870801 [TBL] [Abstract][Full Text] [Related]
16. Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy. Moses KA; Chen LY; Sjoberg DD; Bernstein M; Touijer KA BMC Urol; 2014 Dec; 14():98. PubMed ID: 25495177 [TBL] [Abstract][Full Text] [Related]
17. Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density. Blackwell KL; Bostwick DG; Myers RP; Zincke H; Oesterling JE J Urol; 1994 Jun; 151(6):1565-70. PubMed ID: 7514689 [TBL] [Abstract][Full Text] [Related]
18. Is Hispanic race an independent risk factor for pathological stage in patients undergoing radical prostatectomy? Lam JS; Desai M; Mansukhani MM; Benson MC; Goluboff ET J Urol; 2003 Dec; 170(6 Pt 1):2288-91. PubMed ID: 14634398 [TBL] [Abstract][Full Text] [Related]
19. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340 [TBL] [Abstract][Full Text] [Related]
20. Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen. Zhang W; Sesterhenn IA; Connelly RR; Mostofi FK; Moul JW J Urol; 2000 Jan; 163(1):131-6. PubMed ID: 10604330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]